Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × isophosphamide mustard × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymoma 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 8 Ibandronic Acid 8 Gemcitabine 8 Doxorubicin 8 Cyclophosphamide 8 Specimen Handling 7 pazopanib 6 Biopsy 6 Radiosurgery 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Imatinib Mesylate 5 Bevacizumab 5 regorafenib 4 Zoledronic Acid 4 Irinotecan 4 Docetaxel 4 Radiation 3 Ifosfamide 3 Cryosurgery 3 Carboplatin 3 trastuzumab deruxtecan 2 trametinib 2 temsirolimus 2 sargramostim 2 olaparib 2 masitinib 2 ganitumab 2 futibatinib 2 conatumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01168791 2013-07-18

PICASSO III

Alaunos Therapeutics

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡